Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review
Management of aggressive pituitary adenomas is challenging due to a paucity of rigorous evidence supporting available treatment approaches. Recent guidelines emphasize the need to maximize standard therapies as well as the use of temozolomide and radiation therapy to treat disease recurrence. Howeve...
Guardado en:
Autores principales: | Odelia Cooper, Vivien Bonert, Ning-Ai Liu, Adam N. Mamelak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f20a4e602f0d4dc3aeab27b1c89800d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
por: Changxi Han, et al.
Publicado: (2021) -
Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
por: Oriol Mirallas, et al.
Publicado: (2021) -
Baseline MRI findings as predictors of hypopituitarism in patients with non-functioning pituitary adenomas
por: Reem Al Argan, et al.
Publicado: (2021) -
Adenoma negro de la glándula suprarrenal (Black Adenoma)
por: Castillo C,Octavio A, et al.
Publicado: (2013) -
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
por: Congxin Dai, et al.
Publicado: (2021)